AL158147.2 | HCG2011465; Uncharacterized protein | | | | | | Group enriched |
TUSC5 | Tumor suppressor candidate 5 | Predicted membrane proteins
| | | | | Tissue enriched |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CIDEA | Cell death-inducing DFFA-like effector a | Disease related genes
| | | | | Tissue enriched |
MRAP | Melanocortin 2 receptor accessory protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
HEPN1 | Hepatocellular carcinoma, down-regulated 1 | | | | | | Group enriched |
DEFB132 | Defensin, beta 132 | Predicted secreted proteins
| | | | | Group enriched |
PLIN1 | Perilipin 1 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | Enzymes
| | | | | Group enriched |
AL109927.1 | HCG2032222; PRO2047; Uncharacterized protein | | | | | | Group enriched |
C14orf180 | Chromosome 14 open reading frame 180 | Predicted membrane proteins
| | | | | Group enriched |
LIPE | Lipase, hormone-sensitive | Enzymes
| | | | | Tissue enriched |
KCNIP2 | Kv channel interacting protein 2 | | | | | | Group enriched |
GYG2 | Glycogenin 2 | Enzymes
| | | | | Tissue enriched |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins
| | | | | Tissue enriched |
PRRT4 | Proline-rich transmembrane protein 4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
AQPEP | Aminopeptidase Q | Enzymes Predicted secreted proteins
| | | | | Group enriched |
TBX15 | T-box 15 | Disease related genes Transcription factors
| | | | | Group enriched |
LEP | Leptin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
CDH20 | Cadherin 20, type 2 | Predicted membrane proteins
| | | | | Group enriched |
SCN4A | Sodium channel, voltage-gated, type IV, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
SLC25A18 | Solute carrier family 25 (glutamate carrier), member 18 | Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ALPK3 | Alpha-kinase 3 | Enzymes
| | | | | Group enriched |
LPL | Lipoprotein lipase | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PLIN4 | Perilipin 4 | Plasma proteins
| | | | | Tissue enriched |
SLC7A10 | Solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | Cancer-related genes Transcription factors
| | | | | Tissue enriched |
CIDEC | Cell death-inducing DFFA-like effector c | Disease related genes
| | | | | Tissue enriched |
CSN1S1 | Casein alpha s1 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
LGALS12 | Lectin, galactoside-binding, soluble, 12 | | | | | | Tissue enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes
| | | | | Group enriched |
TIMP4 | TIMP metallopeptidase inhibitor 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AC062017.1 | Uncharacterized protein | | | | | | Group enriched |
ACACB | Acetyl-CoA carboxylase beta | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACVR1C | Activin A receptor, type IC | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
AL445665.1 | Protein LOC100996643 | | | | | | Tissue enriched |
AOC2 | Amine oxidase, copper containing 2 (retina-specific) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
C2CD4C | C2 calcium-dependent domain containing 4C | | | | | | Group enriched |
CDR1 | Cerebellar degeneration-related protein 1, 34kDa | | | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted membrane proteins
| | | | | Group enriched |
DGAT2 | Diacylglycerol O-acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
PNPLA2 | Patatin-like phospholipase domain containing 2 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
PTGER3 | Prostaglandin E receptor 3 (subtype EP3) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
SAA1 | Serum amyloid A1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SAA2 | Serum amyloid A2 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | | | | Group enriched |
SLC29A4 | Solute carrier family 29 (equilibrative nucleoside transporter), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SVEP1 | Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | Predicted secreted proteins
| | | | | Group enriched |